Life sciences

The University of Amsterdam (UvA)’s Faculty of Science, UvA Ventures Holding B.V. and Innovation Exchange Amsterdam (IXA-UvA) are pooling their resources to fund Macrobian Biotech BV, a single asset biotech company that will further develop medicine for the treatment of Parkinson’s disease.

The Secretary of State for Health, Jeremy Hunt MP, was joined by Greg Clark MP and Professor Sir John Bell today (August 30th) at the Institute of Translational Medicine (ITM) - co-located on the University of Birmingham and University Hospitals Birminghamcampus - to make two major national life sciences investment announcements as part of the launch of the Life Sciences Industrial Strategy.

Strategy report calls for funding to create new industries, increased collaboration between pharmaceutical companies and the National Health Service, and incentives to keep the UK attractive to world class scientists after it leaves the EU